Letter to the editor: The addition of C-reactive protein and von Willebrand factor to Model for End-Stage Liver Disease-Sodium

被引：1
|
作者：
Luo, Meng-Si [1 ]
Huang, Guan-Jiang [2 ]
机构：
[1] Guangzhou Univ Chinese Med, Zhongshan Hosp Tradit Chinese Med, Dept Anesthesiol, Zhongshan, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Otorhinolaryngol, 88 Jiefang Rd, Hangzhou 310009, Peoples R China
来源：
HEPATOLOGY | 2022年 / 75卷 / 03期
关键词：
D O I：
10.1002/hep.32252
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：763 / 764
页数：2
相关论文
共 50 条
  • [41] Model for end-stage liver disease limbo, model for end-stage liver disease purgatory, and the dilemma of treating hepatitis C in patients awaiting liver transplantation
    Carrion, Andres F.
    Khaderi, Saira A.
    Sussman, Norman L.
    LIVER TRANSPLANTATION, 2016, 22 (03) : 279 - 280
  • [42] Quantitative and qualitative changes of von Willebrand factor and their impact on mortality in patients with end-stage kidney disease
    Holden, Rachel M.
    Tuttle, Angie
    Burbidge, Toni
    Hegadorn, Carol
    Grabell, Julie
    Pruss, Cynthia
    James, Paula D.
    BLOOD COAGULATION & FIBRINOLYSIS, 2013, 24 (07) : 719 - 726
  • [43] Carbamylation Is Instrumental in End-Stage Kidney Disease Coagulopathies: The Impact on von Willebrand Factor and Platelet Functionality
    Babickova, Janka
    Kalucka, Urszula
    Sochaj-Grzegorczyk, Alicja
    Potempa, Jan
    Scavenius, Carsten
    Knoop, Thomas
    Marti, Hans-Peter
    Kaminska, Marta
    Mydel, Piotr
    THROMBOSIS AND HAEMOSTASIS, 2025, 125 (03) : 230 - 240
  • [44] Comparison of 3 automated assays for C-reactive protein in end-stage renal disease: Clinical and epidemiological implications
    Maggiore, U
    Cristol, JP
    Canaud, B
    Dupuy, AM
    Formica, M
    Pozzato, M
    Panichi, V
    Consani, C
    Metelli, MR
    Sereni, L
    De Nitti, C
    David, S
    Tetta, C
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2005, 145 (06): : 305 - 308
  • [45] C-reactive protein and interleukin-6 as biomarkers of systemic inflammation in end-stage renal disease.
    Honda, H
    Qureshi, AR
    Heimburger, O
    Pecoits-Filho, R
    Stenvinkel, P
    Lindholm, B
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 718A - 718A
  • [46] Serum albumin, inflammation, and nutrition in end-stage renal disease: C-reactive protein is needed for optimal assessment
    Mukai, Hideyuki
    Villafuerte, Hilda
    Qureshi, Abdul Rashid
    Lindholm, Bengt
    Stenvinkel, Peter
    SEMINARS IN DIALYSIS, 2018, 31 (05) : 435 - 439
  • [47] Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease
    Zoccali, C
    Benedetto, FA
    Maas, R
    Mallamaci, F
    Tripepi, G
    Malatino, LS
    Böger, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (02): : 490 - 496
  • [48] Efficacy of simvastatin or ezetimibe on tissue factor, von Willebrand's factor and C-reactive protein in patients with hypercholesterolaemia
    Kostakou, Peggy
    Kolovou, Genovefa
    Anagnostopoulou, Katherine
    Theodoridis, Theodor
    Galea, Vassiliki
    Mihas, Constantinos
    Christopoulou-Cokkinou, Vassiliki
    Cokkinos, Dennis V.
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2010, 103 (01) : 26 - 32
  • [49] VON WILLEBRAND FACTOR, C-REACTIVE PROTEIN, NITRIC OXIDE, AND VASCULAR ENDOTHELIAL GROWTH FACTOR IN A DIETARY REVERSAL MODEL OF HYPERCHOLESTEROLEMIA IN RABBIT
    Haghjooyjavanmard, Shaghayegh
    Nematbakhsh, Mehdi
    Monajemi, Alireza
    Soleimani, Masoud
    BIOMEDICAL PAPERS-OLOMOUC, 2008, 152 (01): : 91 - 95
  • [50] Validation of the Model for End-Stage Liver Disease Sodium Score in the Eurotransplant Region
    Goudsmit, B. F.
    Putter, H.
    Van Hoek, B.
    Braat, A. E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1088 - 1088
12345